MMR Vaccine
Measles · Mumps · Rubella (German measles) · Congenital Rubella Syndrome
Measles has an R0 of 12–18, making it the most contagious vaccine-preventable disease. Pre-vaccine USA: 3–4 million cases and 400–500 deaths annually. Measles causes pneumonia (leading killer), encephalitis (1 in 1,000), and Subacute Sclerosing Panencephalitis (SSPE) — a fatal progressive brain disease occurring years after infection. Rubella during pregnancy causes Congenital Rubella Syndrome — deafness, blindness, heart defects.
Overall Benefit Score
Default scenario · 12-month-old · US community (92% vax rate)
Score for your child →For your child's situation, the evidence strongly supports this vaccine. The disease risk is significant and the vaccine provides substantial protection with a well-established safety record.
📊 Evidence Scores
Scores computed from peer-reviewed data using VaxFact's evidence model. Based on default scenario (12-month-old, standard US community).
🦠 Disease Burden
Measles has an R0 of 12–18, making it the most contagious vaccine-preventable disease. Pre-vaccine USA: 3–4 million cases and 400–500 deaths annually. Measles causes pneumonia (leading killer), encephalitis (1 in 1,000), and Subacute Sclerosing Panencephalitis (SSPE) — a fatal progressive brain disease occurring years after infection. Rubella during pregnancy causes Congenital Rubella Syndrome — deafness, blindness, heart defects.
Measles causes 'immune amnesia' — destroying immunity memory cells and increasing vulnerability to other infections for 2–3 years post-recovery. Children with measles encephalitis have a 25% mortality rate and 25–30% permanent neurological disability among survivors. SSPE is 100% fatal, typically 7–10 years post-measles. Congenital rubella causes deaf-blindness and intellectual disability.
🛡️ Vaccine Effectiveness
Two doses provide lifelong immunity for the vast majority. A small percentage (<3%) of vaccinated individuals have primary or secondary vaccine failure. Population immunity >95% required to maintain herd protection against measles.
Measles outbreaks (e.g., Disneyland 2015, NYC 2019) have almost exclusively occurred in unvaccinated communities or communities with vaccination rates <93–95%.
⚠️ Adverse Events & Side Effects
All probabilities are per 100,000 doses administered, sourced from VAERS, Vaccine Safety Datalink, and post-licensure surveillance studies.
Common Side Effects
Rare Serious Events
📅 Vaccine Schedule
Unvaccinated children and adults: 2 doses 28 days apart. International travel: infants 6–11 months get 1 dose; re-vaccinate at 12–15 months and 4–6 years.
⚖️ Benefits vs. Considerations
✓ Benefits
- 55 years of safety data — the longest record of any combination pediatric vaccine
- The largest, most rigorous vaccine safety study ever conducted (Hviid 2019: 650,000 children) found no autism signal
- Measles immune amnesia means unvaccinated children are vulnerable to many diseases simultaneously post-infection
- SSPE is 100% fatal — the vaccine eliminates this risk entirely
- Protects pregnant contacts and their unborn children from congenital rubella syndrome
- Measles is so contagious (R0=12–18) that even modest drops in coverage cause large outbreaks
- Rubella elimination has nearly eradicated congenital rubella in vaccinated populations
↕ Considerations
- The Wakefield 1998 fraud created lasting vaccine hesitancy that still affects coverage rates globally
- Febrile seizures occur in ~1 per 3,000 doses (real, though typically benign)
- Cannot be given to immunocompromised children — this is an important clinical caveat
- MMR + varicella (MMRV) combination has 2x febrile seizure rate vs. giving vaccines separately
- Contains gelatin stabilizer — relevant for families with religious dietary restrictions
🔬 What Some Researchers Question
These are legitimate scientific debates — not fringe claims. They represent areas of ongoing research or policy disagreement among credentialed experts.
- The Wakefield (1998) MMR-autism claim has been thoroughly refuted by 30+ large studies and over 1.2 million children. Wakefield lost his medical license for research fraud. This is a case study in how a retracted paper caused lasting harm — cited here to document the history, not the science.
- Some virologists raise questions about whether herd immunity thresholds calculated for measles (>95%) adequately account for waning immunity in previously vaccinated adults, who now represent a growing susceptible subpopulation (Dine et al., 2004).
- Critics note that mumps VE has historically been lower (~88%) than measles VE, and college campus outbreaks in vaccinated populations raise questions about mumps component durability (CDC 2019 — Mumps Cases and Outbreaks).
🌫️ Scientific Uncertainties
Honest acknowledgment of what we don't yet know with confidence.
- The exact mechanism of measles immune amnesia and its full long-term consequences are still being characterized
- Whether primary and secondary vaccine failure rates are sufficient to eventually require a 3rd dose in adult years
- Whether the rubella component immunity duration is sufficient for all women of childbearing age vaccinated in childhood
🌍 International Policy Comparison
How different countries approach this vaccine — revealing where global consensus is strong vs. where policy diverges.